Bibliography

Export 273 results:
Filters: Keyword is Transplantation, Homologous  [Clear All Filters]
1999
Przepiorka D, Smith TL, Folloder J, Khouri I, Ueno NT, Mehra R, et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood. 1999;94(4):1465-70.
Curtis RE, Travis LB, Rowlings PA, Socie G, Kingma DW, Banks PM, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999;94(7):2208-16.
1998
Anderlini P, Przepiorka D, Körbling M, Champlin R. Blood stem cell procurement: donor safety issues. Bone Marrow Transplant. 1998;21 Suppl 3:S35-9.
Aho AJ, Hirn M, Aro HT, Heikkila JT, Meurman O. Bone bank service in Finland. Experience of bacteriologic, serologic and clinical results of the Turku Bone Bank 1972-1995. Acta Orthop Scand. 1998;69(6):559-65.
Kuehnert MJ, Clark E, Lockhart SR, Soll DR, Chia J, Jarvis WR. Candida albicans endocarditis associated with a contaminated aortic valve allograft: implications for regulation of allograft processing. Clin Infect Dis. 1998;27(4):688-91.
Arbona C, Prosper F, Benet I, Mena F, Solano C, Garcia-Conde J. Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation. Bone Marrow Transplantation. 1998;22(1):39-45.
1997
Anderlini P, Körbling M, Dale D, Gratwohl A, Schmitz N, Stroncek D, et al. Allogeneic blood stem cell transplantation: considerations for donors. Blood. 1997;90(3):903-8.
CDC. Candida albicans endocarditis associated with a contaminated aortic valve allograft--California, 1996. MMWR MorbMortalWklyRep. 1997;46(12):1.
Bargetzi MJ, Schonenberger A, Tichelli A, Fried R, Cathomas G, Signer E, et al. Celiac disease transmitted by allogeneic non-T cell-depleted bone marrow transplantation. Bone marrow transplantation//Bone Marrow Transplant. 1997;20(7):607-9.
Deijkers RL, Bloem RM, Petit PL, Brand R, Vehmeyer SB, Veen MR. Contamination of bone allografts: analysis of incidence and predisposing factors. J Bone Joint Surg Br. 1997;79(1):161-6.
Chandrasekar PH, Momin F. Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant Team. Bone Marrow Transplant. 1997;19(7):685-689.
Donovan JA, Simmons FA, Esrason KT, Jamehdor M, Busuttil RW, Novak JM, et al. Donor origin of a posttransplant liver allograft malignancy identified by fluorescence in situ hybridization for the Y chromosome and DNA genotyping. Transplantation. 1997;63(1):80-4.
Oziel-Taieb S, Faucher-Barbey C, Chabannon C, Ladaique P, Saux P, Gouin F, et al. Early and fatal immune haemolysis after so-called 'minor' ABO-incompatible peripheral blood stem cell allotransplantation. Bone Marrow Transplant. 1997;19(11):1155-6.
Bosmans JL, Ysebaert D, De Cock AM, Hauben E, Muylle L, Schrijvers D, et al. Interferon-alpha and the cure of metastasis of a malignant meningioma in a kidney allograft recipient: a case report. Transplant Proc. 1997;29(40575):838.
Tran VB, Tran VB, Lin KH. Malaria infection after allogeneic bone marrow transplantation in a child with thalassemia. Bone Marrow Transplant. 1997;19(12):1259-1260.
Teshima A, Harada M. Mobilization of peripheral blood progenitor cells for allogeneic transplantation. Cytokines, Cellular & Molecular Therapy. 1997;3(2):101-14.
Naohara T, Suzuki G, Masauzi N, Ohizumi H, Kobayashi N, Ogasawara M, et al. [Positive seroconversion syphilis in a patient with acute lymphocytic leukemia after allogeneic bone marrow transplantation]. Rinsho Ketsueki. 1997;38(3):228-30.
Becker PS, Wagle M, Matous S, Swanson RS, Pihan G, Lowry PA, et al. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant. 1997;3(1):45-9.
Kishimoto Y, Yamamoto Y, Ito T, Matsumoto N, Ichiyoshi H, Katsurada T, et al. Transfer of autoimmune thyroiditis and resolution of palmoplantar pustular psoriasis following allogeneic bone marrow transplantation. Bone marrow transplantation//Bone Marrow Transplant. 1997;19(10):1041-3.
1996
Harner CD, Olson E, Irrgang JJ, Silverstein S, Fu FH, Silbey M. Allograft versus autograft anterior cruciate ligament reconstruction: 3- to 5-year outcome. Clin Orthop Relat Res. 1996;(324):134-44.
Kealey GP, Aguiar J, Lewis, R. W. 2n, Rosenquist MD, Strauss RG, Bale, J. F. J. Cadaver skin allografts and transmission of human cytomegalovirus to burn patients. JAmCollSurg. 1996;182(3):1.
Korbling M, Anderlini P, Durett A, Maadani F, Bojko P, Seong D, et al. Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation. Bone Marrow Transplantation. 1996;18(6):1073-9.
Lowsky R, Fyles G, Minden M, Lipton J, Meharchand J, Tejpar I, et al. Detection of donor cell derived acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization. Br J Haematol. 1996;93(1):163-5.
Penn I. Evaluation of the candidate with a previous malignancy. Liver Transpl Surg. 1996;2(5 Suppl 1):109-13.
Strong DM, Friedlaender GE, Tomford WW, Springfield DS, Shives TC, Burchardt H, et al. Immunologic responses in human recipients of osseous and osteochondral allografts. Clin Orthop Relat Res. 1996;(326):107-14.

Pages